Ning Wang
- Cancer Research top 0.1%
- Cancer-related molecular mechanisms research 103
- MicroRNA in disease regulation 89
- Pharmacology top 0.05%
- Pharmacological Effects of Natural Compounds 35
- Virology top 0.5%
- Molecular Biology top 0.1%
- RNA modifications and cancer 64
- Circular RNAs in diseases 57
- Epigenetics and DNA Methylation 48
- RNA Research and Splicing 33
- Immunology top 0.5%
-
- Autophagy in Disease and Therapy 40
- Cited by
- Cancer ResearchPharmacologyVirology
- Journals
- PLoS ONE (28 papers)Frontiers in Pharmacology (20 papers)International Journal of Biological Macromolecules (19 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Ning Wang
1.2k papers receiving 34.3k citations
Hit Papers
Peers
Comparison fields: 5 of 231
- Cancer Research 6.0k
- Pharmacology 2.5k
- Virology 1.1k
- Molecular Biology 15.3k
- Immunology 3.8k
Countries citing papers authored by Ning Wang
This map shows the geographic impact of Ning Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Wang more than expected).
Fields of papers citing papers by Ning Wang
This network shows the impact of papers produced by Ning Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Wang. The network helps show where Ning Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ning Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 19 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 3 | |
| 8 | 2023 | 12 | |
| 9 | 2023 | 6 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 25 | |
| 12 | 2023 | 6 | |
| 13 | 2023 | 8 | |
| 14 | 2023 | 3 | |
| 15 | 2023 | 1 | |
| 16 | 2021 | 8 | |
| 17 | 2021 | 6 | |
| 18 | 2016 | 22 | |
| 19 | 2013 | 143 | |
| 20 | 2012 | 107 |
About Ning Wang
Ning Wang is a scholar working on Cancer Research, Pharmacology and Molecular Biology, having authored 1.2k papers that have together received 34.9k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (103 papers), MicroRNA in disease regulation (89 papers), RNA modifications and cancer (64 papers), Circular RNAs in diseases (57 papers), Epigenetics and DNA Methylation (48 papers), Autophagy in Disease and Therapy (40 papers), Pharmacological Effects of Natural Compounds (35 papers) and RNA Research and Splicing (33 papers). The work is most often cited by research in Cancer Research (6.0k citations), Pharmacology (2.5k citations) and Virology (1.1k citations). Ning Wang has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Yibin Feng, Hor‐Yue Tan, Sha Li, Cheng Zhang, Ming Hong, Lixing Lao, Zhang-Jin Zhang, Sai‐Wah Tsao, Xuanbin Wang and Tuofu Zhu. Their work appears in journals such as PLoS ONE, Frontiers in Pharmacology, International Journal of Biological Macromolecules, International Journal of Molecular Sciences and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.